The remaining challenge of pneumonia: The leading killer of children

Pediatric Infectious Disease Journal

Volumn 30, Issue 1, 2011, Pages 1-2

  Dagan, Ron ^a   Bhutta, Zulfiqar A ^b   De Quadros, Ciro A ^c   Garau, Javier ^d   Klugman, Keith P ^e   Khuri Bulos, Najwa ^f   Levine, Orin ^g   Saha, Samir K ^h   Sow, Samba ⁱ   Were, Fred ^j   Yang, Yonghong ^k  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c SABIN VACCINE INSTITUTE   (United States)

^d Clinical Institute of Infectious Diseases and Immunology   (Spain)

^e EMORY UNIVERSITY   (United States)

^f JORDAN UNIVERSITY HOSPITAL   (Jordan)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h DHAKA SHISHU HOSPITAL   (Bangladesh)

ⁱ Center for Vaccine Development   (Mali)

^j Kenya Paediatric Association   (Kenya)

^k CAPITAL MEDICAL UNIVERSITY   (China)

more..

Author keywords

GAVI; Hib; pneumococcal; pneumonia; vaccination

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE;

BACTERIAL PNEUMONIA; CHILD; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; LOWEST INCOME GROUP; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROTYPE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 78650765468     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182005389     Document Type: Article

References (11)

1. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375: 1969-1987.
2. Roth DE, Caulfield LE, Ezzati M, et al. Acute lower respiratory infections in childhood: opportunities for reducing the global burden through nutritional interventions. Bull World Health Organ. 2008;86:356-364.
3. Luby SP, Agboatwalla M, Feikin DR, et al. Effect of handwashing on child health: a randomised controlled trial. Lancet. 2005;366:225-233.
4. Smith KR, Samet JM, Romieu I, et al. Indoor air pollution in developing countries and acute lower respiratory infections in children. Thorax. 2000; 55:518-532.
5. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006. Available at: http://www. surgeongeneral.gov/library/ secondhandsmoke/report/index.html.
6. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet. 1997;349:1191-1197. (Pubitemid 27190041)
7. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365:1139-1146. (Pubitemid 40417563)
8. GAVI Alliance. Investing in immunisation through the GAVI Alliance: the evidence base. Available at: www.gavialliance.org/resources/GAVI-Evidence- Base-2010.pdf
9. Advance Market Commitments (AMC) for Vaccines' Website. Available at: www.vaccineamc.org.
10. The World Health Organization. Pneumococcal conjugate vaccine for childhood immunization, March 2007-WHO position paper. Wkly Epidemiol Rec. 2007; 12 93-104. Available at http://www.who.int/wer.
11. American Academy of Pediatrics. Therapy for children with invasive pneumococcal infections. Pediatrics. 1997;99:289-299.